CNMD CONMED Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: CNMD

Price (delayed)

$136.01

Market cap

$3.97B

P/E Ratio

72.35

Dividend/share

$0.8

EPS

$1.88

Enterprise value

$4.65B

Highlights
The stock's price to earnings (P/E) is 94% less than its last 4 quarters average of 1157.5 and 82% less than its 5-year quarterly average of 401.8
CONMED's gross profit has increased by 16% YoY and by 15% QoQ
CNMD's quick ratio is down by 8% YoY
Sector: Healthcare
Industry: Medical Devices
Website: https://www.conmed.com/
Peers: BSX TFX MDT IART

Key stats

What are the main financial stats of CNMD
Market
Shares outstanding
29.16M
Market cap
$3.97B
Enterprise value
$4.65B
Valuations
Price to earnings (P/E)
72.35
Price to book (P/B)
5.31
Price to sales (P/S)
4.05
EV/EBIT
46.64
EV/EBITDA
39.66
EV/Sales
4.75
Earnings
Revenue
$978.5M
EBIT
$99.69M
EBITDA
$117.25M
Free cash flow
$102.58M
Per share
EPS
$1.88
Free cash flow per share
$3.52
Book value per share
$25.59
Revenue per share
$33.6
TBVPS
$22.56
Balance sheet
Total assets
$1.76B
Total liabilities
$1.02B
Debt
$729.68M
Equity
$744.5M
Working capital
$244.72M
Liquidity
Debt to equity
0.98
Current ratio
2.23
Quick ratio
1.09
Net debt/EBITDA
5.83
Margins
EBITDA margin
12%
Gross margin
55.1%
Net margin
5.5%
Operating margin
10.2%
Efficiency
Return on assets
3.1%
Return on equity
7.6%
Return on invested capital
8.6%
Return on capital employed
6.4%
Return on sales
10.2%
Dividend
Dividend yield
0.59%
DPS
$0.8
Payout ratio
42.6%

CNMD stock price

How has the CONMED stock price performed over time
Intraday
-1.4%
1 week
1.31%
1 month
-2.06%
1 year
64.78%
YTD
21.44%
QTD
-1.03%

Financial performance

How have CONMED's revenue and profit performed over time
Revenue
$978.5M
Gross profit
$539.09M
Operating income
$99.69M
Net income
$54.14M
Gross margin
55.1%
Net margin
5.5%
The operating income has soared by 150% year-on-year and by 89% since the previous quarter
The operating margin has surged by 122% year-on-year and by 70% since the previous quarter
CONMED's gross profit has increased by 16% YoY and by 15% QoQ
CNMD's revenue is up by 12% year-on-year and by 11% since the previous quarter

Growth

What is CONMED's growth rate over time

Valuation

What is CONMED stock price valuation
P/E
72.35
P/B
5.31
P/S
4.05
EV/EBIT
46.64
EV/EBITDA
39.66
EV/Sales
4.75
The stock's price to earnings (P/E) is 94% less than its last 4 quarters average of 1157.5 and 82% less than its 5-year quarterly average of 401.8
The stock's price to book (P/B) is 66% more than its 5-year quarterly average of 3.2 and 15% more than its last 4 quarters average of 4.6
CNMD's equity is up by 10% YoY and by 2.6% from the previous quarter
CNMD's P/S is 62% more than its 5-year quarterly average of 2.5 and 9% more than its last 4 quarters average of 3.7
CNMD's revenue is up by 12% year-on-year and by 11% since the previous quarter

Efficiency

How efficient is CONMED business performance
CNMD's return on invested capital has surged by 161% year-on-year and by 91% since the previous quarter
CNMD's ROS has soared by 122% YoY and by 70% QoQ

Dividends

What is CNMD's dividend history
DPS
$0.8
Dividend yield
0.59%
Payout ratio
42.6%
Recent dividends

Financial health

How did CONMED financials performed over time
CNMD's total assets is 73% greater than its total liabilities
The current ratio has contracted by 11% YoY and by 4.3% from the previous quarter
CNMD's quick ratio is down by 8% YoY
The company's debt to equity fell by 18% YoY and by 4.9% QoQ
CNMD's equity is up by 10% YoY and by 2.6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.